Call for Abstract

Annual Summit on Pain Management - Opioids Drugs, will be organized around the theme “ Preventing Opioidal overdoses and flooding deaths”

Opioids 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Opioids 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Opioids have similar characteristics as that of opium. The main role of opioids is to produce sedation and pain relief. Opioids are the chemicals which that attach to opioids receptors present in the gastrointestinal tract and brain central nervous system to stimulate their upshots. Opioids bind to opioid receptors in the nervous system and other tissues. There are three principal categories of opioid receptors (mu, kappa, and delta).

  • Track 1-1Receptors
  • Track 1-2Signal Transduction
  • Track 1-3Functional Selectivity
  • Track 1-4Equianalgesic
  • Track 1-5Molecular Modeling
  • Track 1-6Therapeutics
  • Track 1-7Signs and Symptoms

Addiction is defined as a chronic, relapsing brain disease that is characterized by compulsive drug seeking and use, despite harmful consequences. It is considered a brain disease because drugs change the brain; they change its structure and how it works.

  • Track 2-1Individual Therapy
  • Track 2-2Recovery-Oriented Challenge Therapy
  • Track 2-3Trauma Therapies
  • Track 2-4Medical and Psychiatric Sessions
  • Track 2-5Psycho-educational and Didactic Groups
  • Track 2-6Family Therapy

The Opioid epidemic or Opioid crisis is the rapid expand in the use of prescription and non-prescription opioids in the United States and Canada in the 2010. Opiates are strong painkillers or analgesic drugs. In 2016, deaths from overdoses increased over the previous year by 26% in Connecticut, 35% in Delaware, 39% in Maine, and 62% in Maryland. In 2015, 52,000 Americans died from drug overdoses, and in 2016 the numbers increased another 19 percent, to approximately 62,000.

  • Track 3-1Prescription Opioid
  • Track 3-2Non-Prescription Opioid
  • Track 3-3Over Dose
  • Track 3-4Economic Impact of the Opioid

Pain management medications alter the insight of pain by reducing the potency of pain signals sent to the brain. Long-term use of opioids as a pain management medication may cause complexions, such as tolerance to the effects of the drug or addiction. It is cautiously planned and closely monitored by a pain medication specialist as a part of an integrated approach to controlling pain. Opioids may not interact well when taken along with other pain management medications.

  • Track 4-1Acute Surgical Pain
  • Track 4-2Chronic non-malignant Pain
  • Track 4-3Comprehensive Opioid Management
  • Track 4-4Use of Opioids in Cancer Survivors
  • Track 4-5Opiods and Osteoarthritis
  • Track 4-6Medical case Reports

Narcotic analgesics are a group of medicines that relieve acute and chronic severe pain by binding to opioid receptors. A drug in small doses dulls the senses, relieves pain, and brings on sleep but in larger doses has dangerous effects, that are used in medicine and others (as heroin) that are used illegally, and that often causes addiction.

  • Track 5-1Codeine
  • Track 5-2Morphine
  • Track 5-3Hydrocodone
  • Track 5-4Fentanyl
  • Track 5-5Heroin

Opioids are a class of impactful drugs that are essentially prescribed to treat acute pain. If opioids are abused, they can create tenderness of intense pleasure or euphoria, and can also lead to fatal overdose, along with other medical, legal and social problems. Opioids include felonious drugs, such as heroin, as well as prescription medications, such as Percocet, morphine and codeine. Opioids are powerful medication when used as prescribed, but they carry a risk of addiction because of their powerful effects. Opioid addiction involves more than just physical dependence.

  • Track 6-1Risks for opioid Addiction
  • Track 6-2Neurobiology of Addiction
  • Track 6-3Behavioral Addictions
  • Track 6-4Adolescent Opioid Addiction
  • Track 6-5Youth Drug Abuse

The current study link has been found between those troubled by mental state disorders and the future use of opioid medicine. The study, featured in a magazine called “Pain” reported that those that suffered from, or who were diagnosed with some type of mental health issue were more susceptible to developing a long-term abuse problem with opioid drugs later in life.

  • Track 7-1Psychosocial Interventions
  • Track 7-2Behavioral Science
  • Track 7-3Relapse Prevention
  • Track 7-4Group and Family Therapy
  • Track 7-5Behavioral Marital Therapy

Opioids are recommended in various guidelines for chronic non-cancer pain because evidence of long term benefit is weak. Opioids have a place in the management of chronic non-cancer pain in carefully selected patients with regular monitoring and as a part of the multimodal therapy. Chronic non-cancer pain including neuropathic pain, case series and randomized controlled trials demonstrates high quality evidence for a weak recommendation for opioids when used in the short term.

  • Track 8-1Opioid- induced Disorder
  • Track 8-2Opioid- induced Mental Disorder
  • Track 8-3Psychological Dependence

Twenty-five states and the District of Columbia, have passed laws since 1996 legalizing the use of medical marijuana for qualifying patients under state law. Medical marijuana programs differ from one another in significant ways, most allow medical marijuana for the treatment of severe, intractable pain. Marijuana’s medical safety and potency are well supported – especially for the treatment of various types of severe and chronic pain.

  • Track 9-1Safety and Efficacy of Medical Marijuana
  • Track 9-2Uses of Marijuana and Opioid
  • Track 9-3Sign and symptoms of Medical Marijuana and Opioids

Buprenorphine is a mixed partial agonist opioid receptor modulator. It is the partial agonist properties of buprenorphine that make it a safe and an effective option for the treatment of opioid addiction. The combination buprenorphine/naloxone is also used for opioid addiction. It is a mixed partial agonist opioid receptor modulator. Buprenorphine is a novel and attractive medication option for many opioid-addicted adults and their physicians.

  • Track 10-1Maintenance Treatment of Buprenorphine Drug
  • Track 10-2Sign and Symptoms of Buprenorphine
  • Track 10-3Buprenorphine Pharmacology

Opioids are used as medicines to cure pain and opioid dependence. If used in excess or without proper medical supervision, opioids can cause fatal respiratory depression. In cases of fatal overdose, the victim’s breathing rate slows to the point where oxygen levels in the blood fall below the level needed to transfer oxygen to the vital organs. As oxygen saturation (normally greater than 97 per cent) falls below 86 per cent, the brain struggles to function. Typically, the individual becomes unresponsive, blood pressure steadily decreases and the heart rate slows, ultimately leading to cardiac arrest. Death can occur within minutes of opioid ingestion. But often, prior to death there is a longer period of unresponsiveness lasting up to several hours. This period is sometimes associated with loud snoring, leading to the term “unarousable snorers”.


  • Track 11-1Prescription Monitoring Program
  • Track 11-2Co-ingestion
  • Track 11-3Naloxone Intervention
  • Track 11-4Best Practices in Opioid Prescription

Cognitive behavioral therapy (CBT) is a psychosocial intervention that is the most widely used evidence-based custom for improving mental health. CBT focuses on the development of personal coping strategies that target solving current trouble and changing unhelpful patterns in cognitions (e.g. thoughts, beliefs, and attitudes), behaviors, and emotional regulation. The CBT model is based on association of the basic principles from behavioral and cognitive psychology.

  • Track 12-1Interpersonal Psychotherapy
  • Track 12-2Moral Reconation Therapy
  • Track 12-3Cognitive Emotional Behavioral Therapy

Opioid rotation refers to a shift from one opioid to another to ameliorate the response to analgesic therapy or reduce adverse effects.  It is a common method to address the trouble of poor opioid responsiveness regardless of optimal dose titration. Opioid rotation or opioid switching is a convention used in the management of severe chronic pain.

  • Track 13-1Induced Hyperalgesia
  • Track 13-2Cross-Tolerance
  • Track 13-3Practice is evolving with respect to Opioid Rotation
  • Track 13-4Reasons for Rotation/Conversion

The progress of effective treatments for opioid dependence is of great importance given the ruinous consequences of the disease. Pharmacotherapies for opioid addiction include opioid agonists, partial agonists, opioid antagonists, and alpha-2-adrenergic agonists, which are earmark toward either detoxification or long-term agonist maintenance. Agonist maintenance therapy is currently the endorsed treatment for opioid dependence due to its superior outcomes relative to detoxification.

  • Track 14-1Medication-Assisted Treatment(MAT)
  • Track 14-2Detoxification
  • Track 14-3Improving the Treatment of Pain

Psychiatry is the medical specialty devoted to the diagnosis, prevention, study, and treatment of mental disorders. These include various abnormalities related to mood, behavior, cognition, and perceptions.

  • Track 15-1Cross-cultural psychiatry
  • Track 15-2Biological psychiatry
  • Track 15-3Neuropsychiatry
  • Track 15-4Emergency psychiatry
  • Track 15-5Addiction psychiatry
  • Track 15-6Sleep medicine
  • Track 15-7 Brain Injury Medicine
  • Track 15-8Clinical neurophysiology
  • Track 15-9Child and Adolescent Psychiatry

Law enforcement is an organization by which some members of society act in a methodical manner to implement the law by discovering, dissuade, rehabilitating, or punishing people who contravene the rules and norms governing that society. Law enforcement may be most concerned with the prevention and punishment of felony, organizations exist to demoralize a wide variety of non-criminal violations of rules and norms, effected through the imposition of less severe consequences.


  • Track 16-1Drug and Chemical Information
  • Track 16-2Law Enforcement Naloxone Toolkit
  • Track 16-3Prescription Drug Fraud and Misuse
  • Track 16-4Mental Health and substance use disorder parity rule for Medicaid and CHIP
  • Track 16-5Drug Enforcement Administration

FDA initiated a risk appraisal and mitigation strategy (REMS) for extended-release and long-acting (ER/LA) opioids that required companies marketing ER/LA opioids to provide a medication direct and make teaching available to prescribers. The training must be provided by accredited providers and cover all elements of the agency's Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics.

  • Track 17-1FDA Issues Guidance on REMS
  • Track 17-2Drug Safety and Risk Management Advisory Committee
  • Track 17-3Anesthetic and Analgesic Drug Products Advisory Committee

Federal and state policy governing opioids is considered to achieve balance between efforts to control drug abuse and maintain drug availability for legitimate medical purposes. Federal law declares the essential medical value of many drugs that are controlled substances, and states that opioids may be used for extended periods in treatment of patients with uncontrollable pain. Physicians should report opioid-dependent patients to the government, regulate prescribing of Schedule II opioids more strictly, and limit the quantity of controlled substances that may be prescribed at one time. Recommendations are offered to revise state laws and to improve communication between health care professionals and regulators.

Medication assisted treatment (MAT) is the use of medications in combination with counseling and behavioral therapies for the treatment of substance use disorders. A combination of medication and behavioral therapies is effective in the treatment of substance use disorders, and can help some people to sustain recovery.

  • Track 19-1Types of Medications
  • Track 19-2Potential Side Effects
  • Track 19-3Protocol for Use of MAT
  • Track 19-4Treatment Options of MAT

Psychology is the science of behavior and mind, embracing all aspects of conscious and unconscious experience as well as thought. Psychologists explore behavior and mental processes, including perception, cognition, attention, emotion (affect), intelligence, phenomenology, motivation (conation), brain functioning, and personality.

  • Track 20-1Social Psychology
  • Track 20-2Behavioral Psychology
  • Track 20-3Cognitive Psychology
  • Track 20-4Neuro Psychology
  • Track 20-5Biological Psychology

Bipolar disorder is also called as manic depression. It is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. The elevated mood is significant and is known as mania or hypomania, depending on its severity, or whether symptoms of psychosis are present.

  • Track 21-1Electroconvulsive Therapy (ECT)
  • Track 21-2Types of bipolar disorder
  • Track 21-3Sleep Medications
  • Track 21-4Diagnosis

Central nervous system diseases are also called as central nervous system disorders, are a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS).

  • Track 22-1Alzheimers Disease
  • Track 22-2Huntingtons disease
  • Track 22-3Parkinsons disease
  • Track 22-4Wilsons disease
  • Track 22-5Tourettes disease

Many new drugs formulation and delivery system have been reinforced that may help further individualize analgesic regimens for those patients with chronic pain. Pain management psychotherapies were primarily limited to short-acting opioid formulations or only those opioids with inherently longer duration of action. The development of technologies that can sway the release and slow absorption of a drug to provide an extended duration of action has led to significant potential benefits for patients with chronic pain. Tamper-resistance formulations could potentially contribute to the reduction of the abuse and misuse of opioids.

  • Track 23-1Fentanyl Formulations
  • Track 23-2Morphine Formulations
  • Track 23-3Oxycodone Formulations
  • Track 23-4Heroin Formulation
  • Track 23-5Transdermal delivery system
  • Track 23-6Delivery in clinical settings

The major pharmacological treatment for acute pain persists to be opioids. Traditional methods of opioid direction are oral, intramuscular, subcutaneous and intravenous. Acute pain management has ameliorated with the introduction of developed techniques for administration of opioids (patient controlled analgesia [PCA] and epidural analgesia). Oral opioids are available as immediate-release (IR) and slow-release (SR) and can be used as step-down analgesia from epidurals or PCAs. Oral morphine has a bioavailability of about 30%--10 mg of IV morphine is roughly equivalent to 30mg of oral morphine.

  • Track 24-1Traditional Methods
  • Track 24-2Opioid-sparing Method
  • Track 24-3Chronic use of opioids

Opioid abuse is a growing problem in the United States. An estimated 2.4 million people in the United States abuse prescription painkillers, and almost half a million people suffer from heroin abuse. people abusing opioids also often face the additional burden of depression.

The relationship between opioid abuse and depression is bi-directional, meaning that suffering from one increases the risk of the other. Opioid abuse is defined as using a prescription opioid for non-medical reasons or using it longer or in greater amounts than what was prescribed by a doctor, and opioid abuse has been linked to higher rates of depression, anxiety, and bipolar disorders.

  • Track 25-1Mixed depression
  • Track 25-2Agitated depression
  • Track 25-3Atypical depression
  • Track 25-4Chronic Depression (Dysthymia)
  • Track 25-5Depression and alcoholism